31
Views
14
CrossRef citations to date
0
Altmetric
Review

Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agents

Pages 55-65 | Published online: 25 Feb 2005
 

Abstract

Inosine monophosphate dehydrogenase (IMPDH), an NAD-dependent enzyme which controls de novo synthesis of purine nucleotides, is an important target for the development of chemotherapeutic agents. The concentration of IMPDH was found to increase in tumour cells and activated lymphocytes. Thus, inhibition of IMPDH would result in anticancer and immunosuppressive activities. Since there is an increased demand for purine nucleotides in virus infected cells needed for RNA and DNA synthesis, inhibition of IMPDH may also lead to antiviral activity. IMPDHs from bacteria, parasites and mammalian sources differ significantly. Such differences can be exploited for the development of antibacterial or antiparasitic agents. Recent progress in revealing the molecular structure, mechanism of action and interactions of the enzyme with the co-factor and inhibitors provided a new stimulus for the development of novel agents targeted against IMPDH. This review covers both academic and industrial studies aimed at inhibition of IMPDH.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.